skip to content

Clinical Neurosciences

Welcome to the Department of Clinical Neurosciences. 

Our mission is to improve the lives of people with neurological disorders. 

We are embedded within Cambridge University Hospitals, allowing our research questions to stem from problems we have encountered in the clinic, and to directly address the needs of patients and families. We work in partnership with the Departments of Psychiatry, Genetics and Paediatrics, to improve Brain and Mind Health, through life, together.

We investigate the mechanisms of brain disease and injury, to devise new diagnostics and treatments, as well as using large data to improve the way we deliver current treatments. Our work has already led to new treatments in use world-wide.

Professor Alasdair Coles
Head of Department

 


 



Latest news

Breakthrough for Global Movement to recognise Traumatic Brain Injury

20 May 2025

GENEVA, SWITZERLAND – In a significant advance for global health policy, the Ministry of Health of Pakistan has confirmed its official sponsorship of a ground-breaking resolution to recognize Traumatic Brain Injury (TBI) as a chronic, notifiable global health condition. "TBI is a global public health crisis hidden in plain...

New paper explores gut dysfunction in Parkinson’s

20 May 2025

Marta Camacho from the Williams-Gray lab has published a new paper defining the characteristics of gut dysfunction in Parkinson's disease. The role of gut dysfunction and its links to neurodegeneration is a very topical issue, with wide interest from both researchers and the media. In this Q&A Marta explains her...

Metabolic driver of Parkinson’s offers new target for treatment

30 April 2025

Researchers led by Dr Sung Min Son and Prof David Rubinsztein (UK DRI at Cambridge) have identified a key enzyme driving forms of Parkinson’s, and have shown how blocking it restores normal function in animal and cell models – offering a promising new drug target for the condition. In Parkinson’s, a protein known as alpha-...